vaccine

Home/Tag: vaccine

Good News from Trio of Phase One Zika Vaccine Trials

In early results published in the Lancet, researchers report that an investigational Zika vaccine was well-tolerated and stimulated potentially protective immune responses in three phase 1 clinical trials, one of which was conducted at Saint Louis University. More than 90 percent of study volunteers in the three trials who received the investigational vaccine demonstrated an immune

December 7th, 2017|Categories: Around The State, Clinical Trials|Tags: , , |

JAMA Findings Reveal Vaccine Approach to Fight Pandemic Bird Flu

Saint Louis University, by Nancy Solomon ~ October 7, 2014 SLU Research: Combine Old and New Vaccines for One, Two Punch Against Deadly Avian Flu ST. LOUIS -- A vaccine that protects against an old strain of avian flu primes the immune system to mount a rapid response when a vaccine designed to protect against

In mice, vaccine stops urinary tract infections linked to catheters

Washington University in St. Louis, by Michael C. Purdy ~ September 17, 2014 The most common type of hospital-associated infection may be preventable with a vaccine, new research in mice suggests. The experimental vaccine, developed by researchers at Washington University School of Medicine in St. Louis, prevented urinary tract infections associated with catheters, the tubes

Consortium Gets EU Funding for Parkinson’s Vaccine

Drug Development & Discover, Source: AFFiRiS AG ~ April 28, 2014 An international consortium of top European research teams has received significant EU funding for the development of therapeutic vaccines against Parkinson's Disease (PD) and Multiple System Atrophy (MSA). Led by the Austrian biotech company AFFiRiS AG, the consortium will use a novel tandem strategy

Novel Therapeutic Cancer Vaccine Goes to Human Clinical Trials

RegenerativeMedicine.net, by Staff ~ October 7, 2013 “It is rare to get a new technology tested in the laboratory and moved into human clinical trials so quickly,” said Dr. Glenn Dranoff. “We’re beyond thrilled with the momentum, and excited about its potential.” A cross-disciplinary team of scientists, engineers, and clinicians announced today that they have

October 7th, 2013|Categories: Cancer, Disease Specific|Tags: , , |